1
Clinical Trials associated with JW-0105A Randomized, Open-label, Single Dose, 2x4 Replicate Crossover Study to Evaluate the Safety and Pharmacokinetic Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105 in Healthy Volunteers
The objective is to evaluate the safety and pharmacokinetic characteristics after co-administration of JW0104 and C2402 and administration of JW0105 in healthy volunteers under fasting conditions.
100 Clinical Results associated with JW-0105
100 Translational Medicine associated with JW-0105
100 Patents (Medical) associated with JW-0105
100 Deals associated with JW-0105